Late-breaking results from Eli Lilly and Company (LLY) and Incyte (INCY) found adolescent patients with severe alopecia areata, AA, treated with once-daily, oral baricitinib 4 mg and 2 mg saw ...
A new awareness-raising effort from Incyte is aimed at giving doctors an up-close look at the emotional and physical challenges their patients with hidradenitis suppurativa (HS) face. HS is a chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback